Completed NA INTERVENTIONAL 2-arm NCT02752932

TumorGraft- Guided Therapy for Improved Outcomes in Head and Neck Squamous Cell Cancer- A Feasibility Study (Xenograft)

Sponsor: Champions Oncology

Conditions Head and Neck Squamous Cell Carcinoma

Interventions Drug testing on PDX per Investigator's choice (upto 4)

Updated 8 times since 2017 Last updated: Oct 16, 2017 Started: Nov 30, 2015 Primary completion: Oct 12, 2017 Completion: Oct 12, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Head and Neck Squamous Cell Carcinoma and is currently completed. Champions Oncology leads this study, which shows 8 recorded versions since 2015 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

8 versions recorded

Apr 2025 — Present [monthly]

Completed NA
Jan 2025 — Apr 2025 [monthly]

Completed NA
Sep 2024 — Jan 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed NA
Nov 2017 — Jun 2018 [monthly]

Completed NA

Status: Recruiting → Completed
Jan 2017 — Nov 2017 [monthly]

Recruiting NA

First recorded

Nov 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Champions Oncology
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Data source: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• London, Canada